These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11089235)

  • 1. Cell-cycle analysis of drug-treated cells.
    Traganos F; Juan G; Darzynkiewicz Z
    Methods Mol Biol; 2001; 95():229-40. PubMed ID: 11089235
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of antitumor drug action assessed by cytometry.
    Traganos F
    Methods Cell Biol; 2004; 75():257-305. PubMed ID: 15603430
    [No Abstract]   [Full Text] [Related]  

  • 3. Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis.
    Inaba M; Mitsuhashi J; Kawada S; Nakano H
    Jpn J Cancer Res; 1994 Feb; 85(2):187-93. PubMed ID: 8144400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity.
    Poot M; Hiller KH; Heimpel S; Hoehn H
    Exp Cell Res; 1995 May; 218(1):326-30. PubMed ID: 7537696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.
    Ellis AL; Nowak B; Plunkett W; Zwelling LA
    Cancer Chemother Pharmacol; 1994; 34(3):249-56. PubMed ID: 8004759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of apoptosis by flow cytometry.
    Gorczyca W; Melamed MR; Darzynkiewicz Z
    Methods Mol Biol; 1998; 91():217-38. PubMed ID: 9664496
    [No Abstract]   [Full Text] [Related]  

  • 7. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells.
    Del Bino G; Skierski JS; Darzynkiewicz Z
    Exp Cell Res; 1991 Aug; 195(2):485-91. PubMed ID: 1649059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of drug uptake-flow cytometry.
    Zoorob G; Burke T
    Methods Mol Biol; 2001; 95():215-27. PubMed ID: 11089234
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular responses to methyl-N-[4-9-acridinylamino)-2-methoxyphenyl] carbamate hydrochloride, an analogue of amsacrine active against non-proliferating cells.
    Moreland N; Finlay GJ; Dragunow M; Holdaway KM; Baguley BC
    Eur J Cancer; 1997 Sep; 33(10):1668-76. PubMed ID: 9389932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of DNA content and BrdU incorporation.
    Darzynkiewicz Z; Juan G
    Curr Protoc Cytom; 2001 May; Chapter 7():Unit 7.7. PubMed ID: 18770734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytometry of antitumor drug-intracellular target interactions.
    Smith PJ; Wiltshire M
    Methods Cell Biol; 2001; 64():173-91. PubMed ID: 11070839
    [No Abstract]   [Full Text] [Related]  

  • 12. Apoptosis of S-phase HL-60 cells induced by DNA topoisomerase inhibitors: detection of DNA strand breaks by flow cytometry using the in situ nick translation assay.
    Gorczyca W; Melamed MR; Darzynkiewicz Z
    Toxicol Lett; 1993 Apr; 67(1-3):249-58. PubMed ID: 8383887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assaying drug-induced apoptosis.
    Darzynkiewicz Z; Juan G; Traganos F
    Methods Mol Biol; 2001; 95():241-54. PubMed ID: 11089236
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered drug interaction and regulation of topoisomerase IIbeta: potential mechanisms governing sensitivity of HL-60 cells to amsacrine and etoposide.
    Grabowski DR; Holmes KA; Aoyama M; Ye Y; Rybicki LA; Bukowski RM; Ganapathi MK; Hickson ID; Ganapathi R
    Mol Pharmacol; 1999 Dec; 56(6):1340-5. PubMed ID: 10570063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle effects of the DNA topoisomerase inhibitors camptothecin and m-AMSA in lymphoblastoid cell lines from patients with Fanconi anemia.
    Poot M; Epe B; Hoehn H
    Mutat Res; 1992 Nov; 270(2):185-9. PubMed ID: 1383735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
    Bertrand R; Solary E; Jenkins J; Pommier Y
    Exp Cell Res; 1993 Aug; 207(2):388-97. PubMed ID: 7688316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of human tumors by laser scanning cytometry.
    Gorczyca W; Deptala A; Bedner E; Li X; Melamed MR; Darzynkiewicz Z
    Methods Cell Biol; 2001; 64():421-43. PubMed ID: 11070850
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of denaturation with HCl on the immunological staining of bromodeoxyuridine incorporated into DNA.
    Sasaki K; Adachi S; Yamamoto T; Murakami T; Tanaka K; Takahashi M
    Cytometry; 1988 Jan; 9(1):93-6. PubMed ID: 2457476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA.
    Lin JH; Castora FJ
    Arch Biochem Biophys; 1995 Dec; 324(2):293-9. PubMed ID: 8554321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic efficacy with combinations of topoisomerase I and topoisomerase II inhibitors in sensitive and multidrug-resistant L1210 mouse leukemia cells.
    Grabowski D; Ganapathi R
    Ann N Y Acad Sci; 1996 Dec; 803():306-7. PubMed ID: 8993524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.